Literature DB >> 26108548

The unexplored relationship between urinary tract infections and the autonomic nervous system.

Michael E Hibbing1, Matt S Conover2, Scott J Hultgren3.   

Abstract

Urinary tract infections (UTIs), the majority of which are caused by uropathogenic E. coli (UPEC), are extremely common infections that preferentially effect women. Additional complicating factors, such as catheterization, diabetes, and spinal cord injuries can increase the frequency and severity of UTIs. The rise of antimicrobial resistant uropathogens and the ability of this disease to chronically recur make the development of alternative preventative and therapeutic modalities a priority. The major symptoms of UTIs, urgency, frequency, and dysuria, are readouts of the autonomic nervous system (ANS) and the majority of the factors that lead to complicated UTIs have been shown to impact ANS function. This review summarizes the decades' long efforts to understand the molecular mechanisms of the interactions between UPEC and the host, with a particular focus on the recent findings revealing the molecular, bacteriological, immunological and epidemiological complexity of pathogenesis. Additionally, we describe the progress that has been made in: i) generating vaccines and anti-virulence compounds that prevent and/or treat UTI by blocking bacterial adherence to urinary tract tissue and; and ii) elucidating the mechanism by which anti-inflammatories are able to alleviate symptoms and improve disease prognosis. Finally, the potential relationships between the ANS and UTI are considered throughout. While these relationships have not been experimentally explored, the known interactions between numerous UTI characteristics (symptoms, complicating factors, and inflammation) and ANS function suggest that UTIs are directly impacting ANS stimulation and that ANS (dys)function may alter UTI prognosis.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autonomic nervous system; Complicated UTI; Therapeutics; Urinary tract infection; Uropathogenic E. coli

Mesh:

Substances:

Year:  2015        PMID: 26108548      PMCID: PMC4670803          DOI: 10.1016/j.autneu.2015.06.002

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  74 in total

1.  B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections.

Authors:  T A Schlager; Robin LeGallo; D Innes; J O Hendley; C A Peters
Journal:  J Urol       Date:  2011-10-22       Impact factor: 7.450

2.  Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection.

Authors:  Erin C Garcia; Ariel R Brumbaugh; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-01-10       Impact factor: 3.441

3.  Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles.

Authors:  M Yoshida; Y Homma; A Inadome; M Yono; H Seshita; Y Miyamoto; S Murakami; K Kawabe; S Ueda
Journal:  Exp Gerontol       Date:  2001-01       Impact factor: 4.032

4.  Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.

Authors:  Drew J Schwartz; Swaine L Chen; Scott J Hultgren; Patrick C Seed
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

Review 5.  Diagnosis and management of urinary tract infection in older adults.

Authors:  Theresa Anne Rowe; Manisha Juthani-Mehta
Journal:  Infect Dis Clin North Am       Date:  2013-12-08       Impact factor: 5.982

Review 6.  Urinary tract infections in special populations: diabetes, renal transplant, HIV infection, and spinal cord injury.

Authors:  Lindsay E Nicolle
Journal:  Infect Dis Clin North Am       Date:  2013-12-08       Impact factor: 5.982

7.  Cholinergic and purinergic responses in isolated human detrusor in relation to age.

Authors:  Melinda Wuest; Kathrin Morgenstern; Eva-Maria Graf; Manfred Braeter; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

8.  Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.

Authors:  Swaine L Chen; Chia S Hung; Jerome S Pinkner; Jennifer N Walker; Corinne K Cusumano; Zhaoli Li; Julie Bouckaert; Jeffrey I Gordon; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

9.  Muscarinic cholinergic receptors in the normal and neurogenic human bladder.

Authors:  H Lepor; D Gup; E Shapiro; M Baumann
Journal:  J Urol       Date:  1989-09       Impact factor: 7.450

10.  In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.

Authors:  X R Wu; T T Sun; J J Medina
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  2 in total

1.  ASIC3 fine-tunes bladder sensory signaling.

Authors:  Nicolas Montalbetti; James G Rooney; Allison L Marciszyn; Marcelo D Carattino
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-21

Review 2.  Epidemiology, definition and treatment of complicated urinary tract infections.

Authors:  Florian M E Wagenlehner; Truls E Bjerklund Johansen; Tommaso Cai; Bela Koves; Jennifer Kranz; Adrian Pilatz; Zafer Tandogdu
Journal:  Nat Rev Urol       Date:  2020-08-25       Impact factor: 14.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.